PSTI Stock Price, News & Analysis
Company Description
PSTI (NASDAQ: PSTI) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $32.3M.
PSTI stock has declined 69.9% over the past year.
This page provides a comprehensive overview of PSTI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
PSTI (PSTI) stock. Over the past 12 months, the stock has lost 69.9%. At a market capitalization of $32.3M, PSTI is classified as a micro-cap stock with approximately 32.3M shares outstanding.
Latest News
PSTI has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include clinical trial, partnership, covid-19. View all PSTI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
PSTI Company Profile & Sector Positioning
PSTI (PSTI) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing PSTI often look at related companies in the same sector, including OnKure Therapeutics (OKUR), Iterum Therapeutics Plc (ITRM), Mural Oncology PLC (MURA), Dyadic Intl Inc Del (DYAI), and AN2 Therapeutics, Inc. (ANTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PSTI's relative position within its industry.